Sleep disorders in Parkinson&rsquo;s disease

Código QR

Sleep disorders in Parkinson&rsquo;s disease

Israt Jahan1, Robert A Hauser2, Kelly L Sullivan1, Amber Miller1, Theresa A Zesiewicz11Department of Neurology, Parkinson&rsquo;s Research Foundation, 2Departments of Neurology, Molecular Pharmacology, and Physiology, University of South Florida, Parkinson&rsquo;s Disease and Movemen...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Israt Jahan, Robert A Hauser, Kelly L Sullivan, Amber Miller, et al.
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2009
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/ada54d0f744c4d79baf8b39f256621ef
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Psychiatric disorders in primary focal dystonia and in Parkinson&rsquo;s disease
por: Fernando MV Dias, et al.
Publicado: (2011)

Parkinson&rsquo;s disease patients&rsquo; subjective descriptions of characteristics of chronic pain, sleeping patterns and health-related quality of life
por: Skogar &Ouml;, et al.
Publicado: (2012)

Beneficial effect of pramipexole for motor function and depression in Parkinson&rsquo;s disease
por: Osamu Kano, et al.
Publicado: (2009)

Rasagiline in treatment of Parkinson&rsquo;s disease
por: Lakshmi Nayak, et al.
Publicado: (2008)

Probable REM sleep behavior disorder is associated with longitudinal cortical thinning in Parkinson’s disease
por: Eun Jin Yoon, et al.
Publicado: (2021)

Current approaches to the treatment of Parkinson&rsquo;s disease
por: Joseph Jankovic, et al.
Publicado: (2008)

Update on ropinirole in the treatment of Parkinson&rsquo;s disease
por: Holly A Shill, et al.
Publicado: (2008)

Ceruloplasmin and iron in Alzheimer&rsquo;s disease and Parkinson&rsquo;s disease: a synopsis of recent studies
por: Kristinsson J, et al.
Publicado: (2012)

Rivastigmine for the treatment of dementia associated with Parkinson&rsquo;s disease
por: Jennifer L Reingold, et al.
Publicado: (2007)

Update on the use of pramipexole in the treatment of Parkinson&rsquo;s disease
por: Radu Constantinescu
Publicado: (2008)

Parkinson&rsquo;s disease and the frequent reasons for emergency admission
por: Ozlem Guneysel, et al.
Publicado: (2008)

Potential cellular and regenerative approaches for the treatment of Parkinson&rsquo;s disease
por: Emma L Lane, et al.
Publicado: (2008)

COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson&rsquo;s disease (PD): relevance for motor and non-motor features
por: Angelo Antonini, et al.
Publicado: (2008)

Depression in Parkinson&rsquo;s disease: Health risks, etiology, and treatment options
por: Pasquale G Frisina, et al.
Publicado: (2008)

A randomized controlled trial of quetiapine for psychosis in Parkinson&rsquo;s disease
por: Paul Shotbolt, et al.
Publicado: (2009)

Depressive symptoms in Parkinson&rsquo;s disease and in non-neurological medical illnesses
por: Assogna F, et al.
Publicado: (2013)

Did depressive symptoms affect recognition of emotional prosody in Parkinson&rsquo;s disease?
por: Adriana V&eacute;lez Feij&oacute;, et al.
Publicado: (2008)

Optimising classification of Parkinson’s disease based on motor, olfactory, neuropsychiatric and sleep features
por: Jonathan P. Bestwick, et al.
Publicado: (2021)

Once-daily pramipexole for the treatment of early and advanced idiopathic Parkinson&rsquo;s disease: implications for patients
por: Antonini A, et al.
Publicado: (2011)

Daytime sleepiness in elderly Parkinson&rsquo;s disease patients and treatment with the psychostimulant modafinil: A preliminary study
por: Johan L&ouml;kk
Publicado: (2010)

Aripiprazole in the treatment of Huntington&rsquo;s disease: a case series
por: Andrea Ciammola, et al.
Publicado: (2008)

Rasagiline for sleep disorders in patients with Parkinson’s disease: a prospective observational study
por: Schettino C, et al.
Publicado: (2016)

Overview of essential tremor
por: Theresa A Zesiewicz, et al.
Publicado: (2010)

Do neurologists in Germany adhere to the national Parkinson&#39;s disease guideline?
por: Sabrina Schr&ouml;der, et al.
Publicado: (2011)

Prevalence of Parkinson’s disease and other types of Parkinsonism in Al Kharga district, Egypt
por: El-Tallawy HN, et al.
Publicado: (2013)

Update on the use of memantine in Alzheimer&rsquo;s disease
por: Robert J van Marum
Publicado: (2009)

Serum metabolic biomarkers for synucleinopathy conversion in isolated REM sleep behavior disorder
por: Ariadna Laguna, et al.
Publicado: (2021)

Abnormal interhemispheric resting state functional connectivity in Parkinson’s disease patients with impulse control disorders
por: Caiting Gan, et al.
Publicado: (2021)

Distinct patterns of speech disorder in early-onset and late-onset de-novo Parkinson’s disease
por: Jan Rusz, et al.
Publicado: (2021)

Sleep apnea leading to Parkinson’s disease – an important association
por: Shafqat MN, et al.
Publicado: (2017)

Optimizing levodopa therapy for Parkinson&rsquo;s disease with levodopa/carbidopa/entacapone: implications from a clinical and patient perspective
por: David J Brooks
Publicado: (2008)

Parkinson’s disease-associated melanin steal
por: Hinz M, et al.
Publicado: (2014)

An update on the toxicity of A&beta; in Alzheimer&rsquo;s disease
por: J&uuml;rgen G&ouml;tz, et al.
Publicado: (2008)

Editor&rsquo;s choice: the best of 2011&ndash;2012
por: Pinder RM
Publicado: (2013)

Heterogeneity of prodromal Parkinson symptoms in siblings of Parkinson disease patients
por: Luca Baldelli, et al.
Publicado: (2021)

Therapeutic interventions and adjustments in the management of Parkinson disease: role of combined carbidopa/levodopa/entacapone (Stalevo&reg;)
por: Paolo Solla, et al.
Publicado: (2010)

Systematic review of the prevalence and incidence of Parkinson’s disease in the People’s Republic of China
por: Zou YM, et al.
Publicado: (2015)

Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease
por: Per Odin, et al.
Publicado: (2018)

Functional imaging of hippocampal dysfunction among persons with Alzheimer&rsquo;s disease: a proof-of-concept study
por: David B Arciniegas, et al.
Publicado: (2010)

Synucleinopathy-associated pathogenesis in Parkinson’s disease and the potential for brain-derived neurotrophic factor
por: Kathryn M. Miller, et al.
Publicado: (2021)